Physician profile
George Day
NPI 1114908175
$829.44
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $168 · 2021: $128.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $171.68 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.38 | 2019-2021 | |
| Alkermes, INC. | $120.87 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $60.11 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.76 | 2019-2021 | |
| Pfizer INC. | $45.51 | 2019-2020 | |
| Amarin Pharma, INC. | $41.37 | 2019-2021 | |
| Glaxosmithkline, LLC. | $38.76 | 2019-2020 | |
| Astellas Pharma US INC | $35.27 | 2020 | |
| Abbvie INC. | $26.95 | 2021 | |
| Lilly USA, LLC | $26.10 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $23.71 | 2020 | |
| Abbott Laboratories | $21.81 | 2019 | |
| Allergan, INC. | $16.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.91 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11.23 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.